FindTrial
Sign In

Clinical study of the effect of Qiang Zhi Granule on the spinal function of patients with kidney yang deficiency and ankylosing spondylitis

Clinical study of the effect of Qiang Zhi Granule on the spinal function of patients with kidney yang deficiency and ankylosing spondylitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013668
Enrollment
Unknown
Registered
2017-12-04
Start date
2016-07-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ankylosing spondylitis

Interventions

treatment group :qiangzhi granules
control group:kidney-invigorating bolus

Sponsors

Shijiazhuang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-45 years old; (2) accords with the standard of Western medical diagnosis; (3) Meet the standard of TCM syndrome diagnosis.

Exclusion criteria

Exclusion criteria: (1) do not meet the inclusion criteria; (2) women have Menopause; (3) patients had used hormone; (4) pregnant or lactating women and psychiatric patients; (5) in alcohol dependent patients; (6) with severe malnutrition, or heart. The brain, kidney and hematopoietic system serious damage; (7) with severe joint deformity; (8) other seronegative spondyloarthropathy, or patients with other rheumatic diseases; (9) known of allergic to traditional Chinese Medicine.

Design outcomes

Primary

MeasureTime frame
VAS;BASFI;enthsisi index;BASDAI;—

Countries

China

Contacts

Public ContactLiang Hui

Shijiazhuang Hospital of Traditional Chinese Medicine

lianghui1119@163.com+86 13303232189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026